Neurive Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
Neurive General Information
Description
Developer of healthcare and medical therapeutic systems designed to bring a new paradigm of treatment. The company specializes in developing digital therapeutics and wearable devices that are in the shape of mobile phones and non-invasive vagus nerve stimulation devices, enabling healthcare companies to provide patients with effective healthcare treatment with medical resolutions and treat conditions like degenerative brain diseases, such as dementia, cognitive dysfunction, depression, and tinnitus.
Contact Information
Website
www.neurive.comCorporate Office
- Room 205, 88
- Somang-gil, Juchon-myeon
- Gimhae, Gyeongsangnam
- South Korea
Corporate Office
- Room 205, 88
- Somang-gil, Juchon-myeon
- Gimhae, Gyeongsangnam
- South Korea
Neurive Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 8. Accelerator/Incubator | 12-Oct-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 6. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 5. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 4. Later Stage VC | 08-Jan-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC | 30-Sep-2021 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jun-2020 | $1.63M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-May-2020 | $1.63M | $1.63M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neurive Patents
Neurive Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025127179-A1 | Vagus nerve stimulation device | Inactive | 12-Dec-2023 | ||
| EP-4523733-A1 | Wireless wearable neural stimulation device | Pending | 27-Jul-2023 | ||
| EP-4523733-A4 | Wireless wearable neural stimulation device | Pending | 27-Jul-2023 | ||
| WO-2025023763-A1 | Wireless wearable neural stimulation device | Inactive | 27-Jul-2023 | ||
| US-20260257063-A1 | Wireless wearable stimulation apparatus for nerve | Pending | 27-Jul-2023 | A61N1/36014 |
Neurive Signals
Neurive Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MUST Accelerator | Accelerator/Incubator | |||
| Gyeongnam Venture Investment | Venture Capital | Minority | ||
| Korea University Holdings | Accelerator/Incubator | Minority | ||
| Incheon Catholic University | University | Minority | ||
| SL Investment | Venture Capital | Minority |
Neurive FAQs
-
When was Neurive founded?
Neurive was founded in 2018.
-
Where is Neurive headquartered?
Neurive is headquartered in Gimhae, South Korea.
-
What is the size of Neurive?
Neurive has 10 total employees.
-
What industry is Neurive in?
Neurive’s primary industry is Therapeutic Devices.
-
Is Neurive a private or public company?
Neurive is a Private company.
-
What is Neurive’s current revenue?
The current revenue for Neurive is .
-
How much funding has Neurive raised over time?
Neurive has raised $2.49M.
-
Who are Neurive’s investors?
MUST Accelerator, Gyeongnam Venture Investment, Korea University Holdings, Incheon Catholic University, and SL Investment are 5 of 10 investors who have invested in Neurive.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process